2.625
price down icon0.94%   -0.025
 
loading
Schlusskurs vom Vortag:
$2.65
Offen:
$2.65
24-Stunden-Volumen:
121.07K
Relative Volume:
0.09
Marktkapitalisierung:
$23.56M
Einnahmen:
$93.76M
Nettoeinkommen (Verlust:
$-13.68M
KGV:
-0.9981
EPS:
-2.63
Netto-Cashflow:
$8.77M
1W Leistung:
+10.76%
1M Leistung:
+22.09%
6M Leistung:
+54.41%
1J Leistung:
-2.78%
1-Tages-Spanne:
Value
$2.55
$2.70
1-Wochen-Bereich:
Value
$2.32
$2.70
52-Wochen-Spanne:
Value
$0.95
$2.85

Aytu Biopharma Inc Stock (AYTU) Company Profile

Name
Firmenname
Aytu Biopharma Inc
Name
Telefon
(720) 437-6580
Name
Adresse
7900 E. UNION AVENUE, DENVER
Name
Mitarbeiter
102
Name
Twitter
@aytubioscience
Name
Nächster Verdiensttermin
2024-12-13
Name
Neueste SEC-Einreichungen
Name
AYTU's Discussions on Twitter

Vergleichen Sie AYTU mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AYTU
Aytu Biopharma Inc
2.625 23.79M 93.76M -13.68M 8.77M -2.63
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.12 68.04B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.48 46.30B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.88 44.25B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.54 18.73B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
304.50 13.82B 2.99B 1.21B 1.13B 25.06

Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-01 Eingeleitet Lake Street Buy
2025-06-30 Eingeleitet Ascendiant Capital Markets Buy
2021-03-30 Eingeleitet Cantor Fitzgerald Overweight
2020-05-29 Eingeleitet H.C. Wainwright Buy

Aytu Biopharma Inc Aktie (AYTU) Neueste Nachrichten

pulisher
Jul 25, 2025

What analysts say about Aytu BioPharma Inc. stockDynamic profit opportunities - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

What risks could impact Aytu BioPharma Inc. stock performanceHigh-velocity capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Aytu BioPharma Inc. stock priceExplosive trading growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Aytu BioPharma Inc. Stock Analysis and ForecastPhenomenal trading returns - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Aytu BioPharma Inc. stock outlookJaw-dropping returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 22, 2025

Is Aytu BioPharma Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

11 Best High Return Penny Stocks to Buy Now - Insider Monkey

Jul 21, 2025
pulisher
Jul 17, 2025

What makes Aytu BioPharma Inc. stock price move sharplyWeekly Big Movers - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Why Aytu BioPharma Inc. stock attracts strong analyst attentionDouble Profit With Half Risk - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

How Aytu BioPharma Inc. stock performs during market volatilityTrending Stock Alert - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Aytu BioPharma Completes $15 Million Debt Refinancing - ACCESS Newswire

Jul 12, 2025
pulisher
Jul 05, 2025

Aytu BioPharma (NASDAQ:AYTU) Downgraded by Wall Street Zen to Buy - Defense World

Jul 05, 2025
pulisher
Jul 04, 2025

Aytu Boosts Liquidity with Eclipse Loan Extension - MSN

Jul 04, 2025
pulisher
Jul 02, 2025

Aytu BioPharma (NASDAQ:AYTU) Now Covered by Lake Street Capital - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

Aytu BioPharma (AYTU): Lake Street Initiates Coverage with Buy Rating | AYTU Stock News - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Lake Street Initiates Aytu BioPharma at Buy With $8 Price Target - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

Aytu BioPharma (NASDAQ:AYTU) Coverage Initiated by Analysts at Ascendiant Capital Markets - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

AYTU: Ascendiant Capital Initiates Coverage with 'Buy' Rating | AYTU Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 30, 2025

This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jun 30, 2025
pulisher
Jun 30, 2025

Aytu BioPharma Receives Orphan Drug Designation from FDA for AR101 for Treatment of Vascular Ehlers-Danlos Syndrome - ACCESS Newswire

Jun 30, 2025
pulisher
Jun 28, 2025

AYTU SEC FilingsAytu Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 28, 2025

Aytu BioPharma (NASDAQ:AYTU) Upgraded by Wall Street Zen to Strong-Buy Rating - Defense World

Jun 28, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 25, 2025

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM) - ACCESS Newswire

Jun 25, 2025
pulisher
Jun 23, 2025

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM) - ACCESS Newswire

Jun 23, 2025
pulisher
Jun 23, 2025

Aytu BioScience Expands Lending Agreement for EXXUA Launch - TipRanks

Jun 23, 2025

Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aytu Biopharma Inc-Aktie (AYTU) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Disbrow Joshua R.
Chief Executive Officer
Jun 09 '25
Buy
1.50
66,666
99,999
153,257
Disbrow Joshua R.
Chief Executive Officer
Feb 28 '25
Buy
1.30
15,000
19,500
86,591
$72.93
price up icon 2.82%
$14.92
price up icon 1.57%
$9.41
price up icon 0.64%
drug_manufacturers_specialty_generic RDY
$14.67
price down icon 0.27%
$132.14
price up icon 0.38%
$304.50
price down icon 0.62%
Kapitalisierung:     |  Volumen (24h):